Adverse Event Reporting
| VAERS ID | 1116381 |
|---|---|
| Gender | Female |
| Age | |
| StateCode | MO |
| Pharmaceutical Company | MODERNA |
| Lot Number | 011A21A |
| Number of vaccinations | 1 |
| Vaccinated | 2021-02-25 |
| Onset | 2021-02-25 |
| Condition | Hospitalized Permanent Disability |
Symptoms
- Gait inability
- Lethargy
Current Illness
MS (had secondary progressive stage MS)
Preexisting Conditions
Other Medications
Previous Vaccinations
Allergies
Laboratory Data
Write-up
could not walk; Lethargic; A spontaneous report was received a consumer (patient's husband) for a 72-year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced she was lethargic and could not walk.
The patient had secondary progressive stage MS.
On 25-Feb-2021, the patient received her first of two planned doses of mRNA-1273 (Lot number: 011A21A) intramuscularly for prophylaxis of COVID-19 infection.
20 hours after the injection on 26-Feb-2021 she was lethargic and could not walk.
Patient's husband called an ambulance and she was transported to the hospital.
The patient was hospitalized at the time of reporting.
She was currently needing physical therapy.
The patient had a similar event 1 year ago.
Seriousness criteria for all events was hospitalization.
Treatment information was unknown.
Action taken with mRNA-1273 was unknown.
The outcome of the events was unknown.
; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.